Automating Blood Smears Developed for Easier Malaria Diagnosis
By LabMedica International staff writers Posted on 03 Feb 2022 |

Image: (a) 3D-rendered exploded view of autohaem smear showing the non-3D printed parts. (b) Photo of an autohaem smear showing the assembled device with the two microscope slides in their positions (Photo courtesy of Cambridge University)
Blood smears are used in diagnosis for a variety of hematological disorders, such as anemia and leukemia. They are also the preferred method of diagnosis of parasitic infections, such as malaria and filariasis in developing world laboratories.
The current “gold standard” for malaria diagnosis is by optical microscopy examination of blood smears. A thin film of the patients’ bloods is fixed onto a microscope slide and stained. The microscopists look at the smear, counting the parasites in various fields of view. These experts can establish the species of malaria and parasite density.
Bioengineers at Cambridge University (Cambridge, UK) collaborating with their colleagues in Tanzania and the UK created a series of devices, which they call “autohaem.” Autohaem devices aim at enabling even non-experts to produce consistent, high quality, thin film blood smears at low cost. The autohaem devices, solves this problem by automating the smearing process so every smear is correct and consistent. The devices come in two varieties, the autohaem smear and the autohaem smear+, the latter of which is fully automated with a motorized smearing mechanism. In tests, inexperienced technicians were able to use the device to produce expert-quality smears.
A key goal of the project was to make the devices accessible to as many people as possible, so the scientists designed their devices to be easy to build, using readily available or 3D-printed components. A pipeline for automated analysis of smear quality was presented and used for device optimization. Red Blood Cells (RBCs), at the typical hematocrit for malaria investigations, are used as the testing media. This pipeline will also be suitable for a more systematic analysis of blood smear preparation, for example, to help with training and evaluation of technicians.
Samuel McDermott, PhD, the senior author of the study, said, “Creating blood smears is a laborious, repetitive task that requires an expert level of skill and manual dexterity. By using automated blood smearing machines, such as autohaem devices, technicians will be able to increase their throughput while maintaining a high enough quality for diagnosis. In some countries, up to 81.5% of blood smears are prepared incorrectly. If a blood smear is prepared incorrectly, when examined under a microscope, the technician will struggle to make a correct diagnosis. Because these smears are often made in a rural clinic and sent to a regional facility for examination, any issues in the smear could cause days of delay.”
The authors concluded that they have developed and presented the autohaem range of devices for automated blood smearing. Autohaem smear is a mechanical device, and autohaem smear+ is an electro-mechanical device. The devices are designed to be sustainable and all the designs and assembly instructions are available under an open source license. The study was published on January 18, 2022, in the journal Review of Scientific Instruments.
Related Links:
Cambridge University
The current “gold standard” for malaria diagnosis is by optical microscopy examination of blood smears. A thin film of the patients’ bloods is fixed onto a microscope slide and stained. The microscopists look at the smear, counting the parasites in various fields of view. These experts can establish the species of malaria and parasite density.
Bioengineers at Cambridge University (Cambridge, UK) collaborating with their colleagues in Tanzania and the UK created a series of devices, which they call “autohaem.” Autohaem devices aim at enabling even non-experts to produce consistent, high quality, thin film blood smears at low cost. The autohaem devices, solves this problem by automating the smearing process so every smear is correct and consistent. The devices come in two varieties, the autohaem smear and the autohaem smear+, the latter of which is fully automated with a motorized smearing mechanism. In tests, inexperienced technicians were able to use the device to produce expert-quality smears.
A key goal of the project was to make the devices accessible to as many people as possible, so the scientists designed their devices to be easy to build, using readily available or 3D-printed components. A pipeline for automated analysis of smear quality was presented and used for device optimization. Red Blood Cells (RBCs), at the typical hematocrit for malaria investigations, are used as the testing media. This pipeline will also be suitable for a more systematic analysis of blood smear preparation, for example, to help with training and evaluation of technicians.
Samuel McDermott, PhD, the senior author of the study, said, “Creating blood smears is a laborious, repetitive task that requires an expert level of skill and manual dexterity. By using automated blood smearing machines, such as autohaem devices, technicians will be able to increase their throughput while maintaining a high enough quality for diagnosis. In some countries, up to 81.5% of blood smears are prepared incorrectly. If a blood smear is prepared incorrectly, when examined under a microscope, the technician will struggle to make a correct diagnosis. Because these smears are often made in a rural clinic and sent to a regional facility for examination, any issues in the smear could cause days of delay.”
The authors concluded that they have developed and presented the autohaem range of devices for automated blood smearing. Autohaem smear is a mechanical device, and autohaem smear+ is an electro-mechanical device. The devices are designed to be sustainable and all the designs and assembly instructions are available under an open source license. The study was published on January 18, 2022, in the journal Review of Scientific Instruments.
Related Links:
Cambridge University
Latest Technology News
- New Diagnostic System Achieves PCR Testing Accuracy
- DNA Biosensor Enables Early Diagnosis of Cervical Cancer
- Self-Heating Microfluidic Devices Can Detect Diseases in Tiny Blood or Fluid Samples
- Breakthrough in Diagnostic Technology Could Make On-The-Spot Testing Widely Accessible
- First of Its Kind Technology Detects Glucose in Human Saliva
- Electrochemical Device Identifies People at Higher Risk for Osteoporosis Using Single Blood Drop
- Novel Noninvasive Test Detects Malaria Infection without Blood Sample
- Portable Optofluidic Sensing Devices Could Simultaneously Perform Variety of Medical Tests
- Point-of-Care Software Solution Helps Manage Disparate POCT Scenarios across Patient Testing Locations
- Electronic Biosensor Detects Biomarkers in Whole Blood Samples without Addition of Reagents
- Breakthrough Test Detects Biological Markers Related to Wider Variety of Cancers
- Rapid POC Sensing Kit to Determine Gut Health from Blood Serum and Stool Samples
- Device Converts Smartphone into Fluorescence Microscope for Just USD 50
- Wi-Fi Enabled Handheld Tube Reader Designed for Easy Portability
Channels
Clinical Chemistry
view channel
3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models
Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more.jpg)
POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection
Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more
Highly Reliable Cell-Based Assay Enables Accurate Diagnosis of Endocrine Diseases
The conventional methods for measuring free cortisol, the body's stress hormone, from blood or saliva are quite demanding and require sample processing. The most common method, therefore, involves collecting... Read moreMolecular Diagnostics
view channel
Unique Autoantibody Signature to Help Diagnose Multiple Sclerosis Years before Symptom Onset
Autoimmune diseases such as multiple sclerosis (MS) are thought to occur partly due to unusual immune responses to common infections. Early MS symptoms, including dizziness, spasms, and fatigue, often... Read more
Blood Test Could Detect HPV-Associated Cancers 10 Years before Clinical Diagnosis
Human papilloma virus (HPV) is known to cause various cancers, including those of the genitals, anus, mouth, throat, and cervix. HPV-associated oropharyngeal cancer (HPV+OPSCC) is the most common HPV-associated... Read moreHematology
view channel
Next Generation Instrument Screens for Hemoglobin Disorders in Newborns
Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more
First 4-in-1 Nucleic Acid Test for Arbovirus Screening to Reduce Risk of Transfusion-Transmitted Infections
Arboviruses represent an emerging global health threat, exacerbated by climate change and increased international travel that is facilitating their spread across new regions. Chikungunya, dengue, West... Read more
POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy
Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more
First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy
Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read moreImmunology
view channel
Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies
Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more
AI Tool Precisely Matches Cancer Drugs to Patients Using Information from Each Tumor Cell
Current strategies for matching cancer patients with specific treatments often depend on bulk sequencing of tumor DNA and RNA, which provides an average profile from all cells within a tumor sample.... Read more
Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment
Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read moreMicrobiology
view channel
Mouth Bacteria Test Could Predict Colon Cancer Progression
Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more.jpg)
Unique Metabolic Signature Could Enable Sepsis Diagnosis within One Hour of Blood Collection
Sepsis is a life-threatening condition triggered by an extreme response of the body to an infection. It requires immediate medical intervention to prevent potential death or lasting damage.... Read morePathology
view channel
Spatial Tissue Analysis Identifies Patterns Associated With Ovarian Cancer Relapse
High-grade serous ovarian carcinoma is the most lethal type of ovarian cancer, and it poses significant detection challenges. Typically, patients initially respond to surgery and chemotherapy, but the... Read more.jpg)
Unique Hand-Warming Technology Supports High-Quality Fingertip Blood Sample Collection
Warming the hand is an effective way to facilitate blood collection from a fingertip, yet off-the-shelf solutions often do not fulfill laboratory requirements. Now, a unique hand-warming technology has... Read moreIndustry
view channel
ECCMID Congress Name Changes to ESCMID Global
Over the last few years, the European Society of Clinical Microbiology and Infectious Diseases (ESCMID, Basel, Switzerland) has evolved remarkably. The society is now stronger and broader than ever before... Read more
Bosch and Randox Partner to Make Strategic Investment in Vivalytic Analysis Platform
Given the presence of so many diseases, determining whether a patient is presenting the symptoms of a simple cold, the flu, or something as severe as life-threatening meningitis is usually only possible... Read more